Literature DB >> 20825436

Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain.

D Viasus1, J R Paño-Pardo, J Pachón, A Campins, F López-Medrano, A Villoslada, M C Fariñas, A Moreno, J Rodríguez-Baño, J A Oteo, J Martínez-Montauti, J Torre-Cisneros, F Segura, F Gudiol, J Carratalà.   

Abstract

The risk factors for complications in patients with influenza A (H1N1)v virus infection have not been fully elucidated. We performed an observational analysis of a prospective cohort of hospitalized adults with confirmed pandemic influenza A (H1N1)v virus infection at 13 hospitals in Spain, between June 12 and November 10, 2009, to identify factors associated with severe disease. Severe disease was defined as the composite outcome of intensive-care unit (ICU) admission or in-hospital mortality. During the study period, 585 adult patients (median age 40 years) required hospitalization because of pandemic (H1N1) 2009. At least one comorbid condition was present in 318 (54.4%) patients. Pneumonia was diagnosed in 234 (43.2%) patients and bacterial co-infection in 45 (7.6%). Severe disease occurred in 75 (12.8%) patients, of whom 71 required ICU admission and 13 (2.2%) died. Independent factors for severe disease were age <50 years (OR, 2.39; 95% CI, 1.05-5.47), chronic comorbid conditions (OR, 2.93; 95% CI, 1.41-6.09), morbid obesity (OR, 6.7; 95% CI, 2.25-20.19), concomitant and secondary bacterial co-infection (OR, 2.78; 95% CI, 1.11-7) and early oseltamivir therapy (OR, 0.32; 95% CI 0.16-0.63). In conclusion, although adults hospitalized for pandemic (H1N1) 2009 suffer from significant morbidity, mortality is lower than that reported in the earliest studies. Younger age, chronic comorbid conditions, morbid obesity and bacterial co-infection are independent risk factors for severe disease, whereas early oseltamivir therapy is a protective factor.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20825436     DOI: 10.1111/j.1469-0691.2010.03362.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  39 in total

1.  Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection.

Authors:  Bárbara Borgatta; Marcos Pérez; J Rello; Loreto Vidaur; Leonardo Lorente; Lorenzo Socías; Juan Carlos Pozo; J C Pozo; José Garnacho-Montero; Jordi Rello
Journal:  Intensive Care Med       Date:  2012-04-18       Impact factor: 17.440

2.  Overtreating or underdiagnosing invasive pulmonary aspergillosis (IPA) in critically ill H1N1 patients: who is right?

Authors:  Ignacio Martin-Loeches; Jordi Valles
Journal:  Intensive Care Med       Date:  2012-08-16       Impact factor: 17.440

Review 3.  Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Authors:  Jonathan Hsu; Nancy Santesso; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

Review 4.  Management of community-acquired pneumonia in older adults.

Authors:  Antonella F Simonetti; Diego Viasus; Carolina Garcia-Vidal; Jordi Carratalà
Journal:  Ther Adv Infect Dis       Date:  2014-02

5.  Impact of obesity on outcomes for patients hospitalised with pneumonia.

Authors:  Phoebe King; Eric M Mortensen; Mary Bollinger; Marcos I Restrepo; Laurel A Copeland; Mary Jo V Pugh; Brandy Nakashima; Antonio Anzueto; Polly Hitchcock Noël
Journal:  Eur Respir J       Date:  2012-08-30       Impact factor: 16.671

Review 6.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

Review 7.  Review on the impact of pregnancy and obesity on influenza virus infection.

Authors:  Erik A Karlsson; Glendie Marcelin; Richard J Webby; Stacey Schultz-Cherry
Journal:  Influenza Other Respir Viruses       Date:  2012-02-15       Impact factor: 4.380

Review 8.  Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition.

Authors:  Gabriella Pugliese; Alessia Liccardi; Chiara Graziadio; Luigi Barrea; Giovanna Muscogiuri; Annamaria Colao
Journal:  Int J Obes (Lond)       Date:  2022-01-21       Impact factor: 5.095

9.  Utility of the first few100 approach during the 2009 influenza A(H1N1) pandemic in the Netherlands.

Authors:  Arianne B van Gageldonk-Lafeber; Marianne Ab van der Sande; Adam Meijer; Ingrid Hm Friesema; Gé A Donker; Johan Reimerink; Mirna Robert-Du Ry van Beest Holle; Jan M Prins; Leslie Isken; François G Schellevis; Mariken Im van der Lubben
Journal:  Antimicrob Resist Infect Control       Date:  2012-09-21       Impact factor: 4.887

10.  Changes in severity of influenza A(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany.

Authors:  Nicola Lehners; Steffen Geis; Christoph Eisenbach; Kai Neben; Paul Schnitzler
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.